Thomas Dustin M, Lee Joshua S, Charmforoush Anthony, Rubal Bernard J, Rosenblatt Stephen A, Butler Joshua T, Clemenshaw Michael, Cheezum Michael K, Slim Ahmad M
Cardiology Service MCHE-MDC, San Antonio Military Medical Center, 3551 Roger Brooke Drive, San Antonio, TX 78234-6200, USA
Cardiology Service, San Antonio Military Medical Center, San Antonio, TX, USA.
Ther Adv Cardiovasc Dis. 2015 Dec;9(6):366-74. doi: 10.1177/1753944715593905. Epub 2015 Jul 24.
Small, observational trials have suggested a reduction in adjacent gastric activity with ingestion of soda water in myocardial perfusion imaging (MPI). We report our findings prior to and after implementation of soda water in 467 consecutive MPI studies.
Consecutive MPI studies performed at a high-volume facility referred for vasodilator (VD) or exercise treadmill testing (ETT) were retrospectively reviewed before and after implementation of the soda water protocol. Patients undergoing the soda water protocol received 100 ml of soda water administered 30 min prior to image acquisition and after stress. Studies were performed using a same day rest/stress protocol. Incidence of adjacent gastric activity, diaphragmatic attenuation, stress and rest perfusion defects, and major adverse cardiovascular events (MACE) outcomes defined as death, myocardial infarction, stroke, reevaluation for chest pain, and late revascularization (>90 days from MPI) were abstracted using International Classification of Diseases, Ninth Revision (ICD-9) search.
Two hundred and eighteen studies were performed prior to implementation of the soda water protocol and 249 studies were performed with the use of soda water. Baseline demographic data were equal between the groups with the exception of more patients undergoing VD stress receiving soda water (p < 0.001). Soda water was not associated with a decreased incidence of adjacent gastric activity with stress (54.7% versus 61.9% with no soda water, p = 0.129) or rest (68.6% versus 69.5% with no soda water, p = 0.919) imaging. Less adjacent gastric activity was observed with patients undergoing ETT who received soda water (42.5% versus 56.9% with no soda water, p = 0.031), but no difference was observed between the groups with VD stress (69.0% versus 68.1% with no soda water, p = 1.000).
The use of soda water prior to technetium-99m MPI was associated with lower rates of adjacent gastric activity only in patients undergoing ETT stress but not rest or VD stress. This differs from previously published data.
小型观察性试验表明,在心肌灌注成像(MPI)中摄入苏打水可减少邻近胃的活动。我们报告了在连续467项MPI研究中实施苏打水前后的研究结果。
对一家大型机构进行的用于血管扩张剂(VD)或运动平板试验(ETT)的连续MPI研究在实施苏打水方案前后进行回顾性分析。接受苏打水方案的患者在图像采集前30分钟和负荷后接受100毫升苏打水。研究采用同日静息/负荷方案。使用国际疾病分类第九版(ICD-9)搜索提取邻近胃活动、膈肌衰减、负荷和静息灌注缺损以及主要不良心血管事件(MACE)结局的发生率,MACE结局定义为死亡、心肌梗死、中风、因胸痛进行的重新评估以及晚期血运重建(MPI后>90天)。
在实施苏打水方案之前进行了218项研究,使用苏打水进行了249项研究。除了更多接受VD负荷的患者接受苏打水外(p<0.001),两组之间的基线人口统计学数据相同。苏打水与负荷时(54.7%对未饮用苏打水时的61.9%,p=0.129)或静息时(68.6%对未饮用苏打水时的69.5%,p=0.919)邻近胃活动发生率降低无关。接受苏打水的ETT患者观察到的邻近胃活动较少(42.5%对未饮用苏打水时的56.9%,p=0.031),但VD负荷组之间未观察到差异(69.0%对未饮用苏打水时的68.1%,p=1.000)。
仅在接受ETT负荷而非静息或VD负荷的患者中,在锝-99m MPI之前使用苏打水与较低的邻近胃活动率相关。这与先前发表的数据不同。